Research output per year
Research output per year
Research output
Search results
-
2021
HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.
Mayr, C. R., Kiesslich, T., Erber, S., Bekric, D., Dobias, H., Ritter, M., Jäger, T., Neumayer, Klieser, E. & Neureiter, D., 2021.Research output: Contribution to conference › unpublished Abstract
-
HDAC-targeting Epigenetic Drug Screening for Biliary Tract Cancer.
Mayr, C. R. (First author), Kiesslich, T. (Co-author), Erber, S. (Co-author), Bekric, D. (Co-author), Dobias, H. (Co-author), Ritter, M. (Co-author), Jäger, T. (Co-author), Neumayer, B. (Co-author), Winkelmann, P. (Co-author), Klieser, E. (Co-author) & Neureiter, D. (Last author), 2021.Research output: Contribution to conference › unpublished Abstract